TetraScience (United States)

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

• Chemistry 10.6×
• Biochemistry, Genetics and Molecular Biology 9.4×
• Materials Science 2.4×
• Engineering 1.7×

By fractional works in all years, weighted toward what it does more of than the world: Epidemiology, Dry Eye Disease, Ocular Surface, Wound Healing, Tissue Engineering, Corneal Regeneration, Limbal Stem Cells and Biomarkers.

By volume in 2022–2025: Innovative Microfluidic and Catalytic Techniques Innovation, Genetics, Bioinformatics, and Biomedical Research, Cell Image Analysis Techniques and Photochromic and Fluorescence Chemistry.

1. 1 Innovative Microfluidic and Catalytic Techniques Innovation Biomedical Engineering 0 works
2. 2 Genetics, Bioinformatics, and Biomedical Research Molecular Biology 0 works
3. 3 Cell Image Analysis Techniques Biophysics 0 works
4. 4 Photochromic and Fluorescence Chemistry Materials Chemistry 0 works
5. 5 Molecular spectroscopy and chirality Spectroscopy 0 works
6. 6 Synthesis and Properties of Aromatic Compounds Organic Chemistry 0 works

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

Output in 2018–2022 was 85% lower than in 2013–2017.

• Boston University
• Massachusetts General Hospital
• Brigham and Women's Hospital
• Northeastern University
• Boston Children's Hospital
• Boston College
• Beth Israel Deaconess Medical Center
• General Electric (United States)